Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020).
Al-Qahtani M, Behe M, Bormans G, Carlucci G, Dasilva J, Decristoforo C, Elsinga PH, Kopka K, Li XG, Mach R, Middel O, Passchier J, Patt M, Penuelas I, Rey A, Scott PJH, Todde S, Toyohara J, Vugts D. Al-Qahtani M, et al. Among authors: vugts d. EJNMMI Radiopharm Chem. 2021 Jan 28;6(1):5. doi: 10.1186/s41181-020-00118-5. EJNMMI Radiopharm Chem. 2021. PMID: 33507426 Free PMC article. Review.
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
Miedema IHC, Huisman MC, Zwezerijnen GJC, Grempler R, Pitarch AP, Thiele A, Hesse R, Elgadi M, Peltzer A, Vugts DJ, van Dongen GAMS, de Gruijl TD, Menke-van der Houven van Oordt CW, Bahce I. Miedema IHC, et al. Among authors: vugts dj. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2068-2080. doi: 10.1007/s00259-023-06164-w. Epub 2023 Mar 2. Eur J Nucl Med Mol Imaging. 2023. PMID: 36859619 Free PMC article.
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET.
Pouw JEE, Hashemi SMS, Huisman MC, Wijngaarden JE, Slebe M, Oprea-Lager DE, Zwezerijnen GJC, Vugts D, Ulas EB, de Gruijl TD, Radonic T, Senan S, Menke-van der Houven van Oordt CW, Bahce I. Pouw JEE, et al. Among authors: vugts d. J Immunother Cancer. 2024 Feb 1;12(2):e007659. doi: 10.1136/jitc-2023-007659. J Immunother Cancer. 2024. PMID: 38302416 Free PMC article.
89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study.
Linders DGJ, Deken MM, van Dam MA, Wasser MNJM, Voormolen EMC, Kroep JR, van Dongen GAMS, Vugts D, Oosterkamp HM, Straver ME, van de Velde CJH, Cohen D, Dibbets-Schneider P, van Velden FHP, Pereira Arias-Bouda LM, Vahrmeijer AL, Liefers GJ, de Geus-Oei LF, Hilling DE. Linders DGJ, et al. Among authors: vugts d. Cancers (Basel). 2023 Oct 13;15(20):4980. doi: 10.3390/cancers15204980. Cancers (Basel). 2023. PMID: 37894346 Free PMC article.
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles.
Rijcken CJF, De Lorenzi F, Biancacci I, Hanssen RGJM, Thewissen M, Hu Q, Atrafi F, Liskamp RMJ, Mathijssen RHJ, Miedema IHC, Menke-van der Houven van Oordt CW, van Dongen GAMS, Vugts DJ, Timmers M, Hennink WE, Lammers T. Rijcken CJF, et al. Adv Drug Deliv Rev. 2022 Dec;191:114613. doi: 10.1016/j.addr.2022.114613. Epub 2022 Nov 4. Adv Drug Deliv Rev. 2022. PMID: 36343757 Review.
PET Imaging of Microglial Activation-Beyond Targeting TSPO.
Janssen B, Vugts DJ, Windhorst AD, Mach RH. Janssen B, et al. Among authors: vugts dj. Molecules. 2018 Mar 8;23(3):607. doi: 10.3390/molecules23030607. Molecules. 2018. PMID: 29518005 Free PMC article. Review.
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Aime S, Al-Qahtani M, Behe M, Bormans G, Carlucci G, DaSilva JN, Decristoforo C, Duatti A, Elsinga PH, Kopka K, Li XG, Liu Z, Mach RH, Middel O, Passchier J, Patt M, Penuelas I, Rey A, Scott PJH, Todde S, Toyohara J, Vugts D, Yang Z. Aime S, et al. Among authors: vugts d. EJNMMI Radiopharm Chem. 2021 Mar 18;6(1):13. doi: 10.1186/s41181-021-00128-x. EJNMMI Radiopharm Chem. 2021. PMID: 33738618 Free PMC article. Review.
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.
Högnäsbacka AA, Poot AJ, Plisson C, Bergare J, Bonsall DR, McCluskey SP, Wells LA, Kooijman E, Schuit RC, Verlaan M, Beaino W, van Dongen GAMS, Vugts DJ, Elmore CS, Passchier J, Windhorst AD. Högnäsbacka AA, et al. Among authors: vugts dj. EJNMMI Res. 2024 Feb 16;14(1):19. doi: 10.1186/s13550-024-01078-6. EJNMMI Res. 2024. PMID: 38363422 Free PMC article.
118 results